Additionally, the hepatitis B virus (HBV) can suppress ferroptosis by decreasing intracellular iron (Fe2 + ) concentrations and upregulating GPX4 through the SRSF2/PCLAF pathway, which diminishes HCC sensitivity to sorafenib [59]. The gene discussed is GPX4; the disease is hepatocellular carcinoma.